v3.25.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Ordinary Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balances at Dec. 31, 2023   $ 1,122,164 $ (65) $ (909,104) $ 212,995
Balance (in shares) at Dec. 31, 2023 48,091        
Increase (Decrease) in Stockholders' Equity          
Repurchase of ordinary shares, net of transaction costs   (445)     (445)
Repurchase of ordinary shares, net of transaction costs (in shares) (38)        
Employee share-based compensation expense   5,229     5,229
Issuance of restricted shares (in shares) 658        
Repurchase of shares to satisfy tax withholding   (1,271)     (1,271)
Repurchase of shares to satisfy tax withholding (in shares) (145)        
Net unrealized gain (loss) on marketable securities     24   24
Net loss       (11,664) (11,664)
Balances at Mar. 31, 2024   1,125,677 (41) (920,768) 204,868
Balance (in shares) at Mar. 31, 2024 48,566        
Balances at Dec. 31, 2024   1,141,060 7 (965,522) $ 175,545
Balance (in shares) at Dec. 31, 2024 49,471       49,471
Increase (Decrease) in Stockholders' Equity          
Proceeds from ESPP purchases   20     $ 20
Proceeds from ESPP purchases (in shares) 2        
Employee share-based compensation expense   4,877     4,877
Issuance of restricted shares $ 1       1
Issuance of restricted shares (in shares) 619        
Repurchase of shares to satisfy tax withholding   (874)     (874)
Repurchase of shares to satisfy tax withholding (in shares) (91)        
Net unrealized gain (loss) on marketable securities     $ (7)   (7)
Net loss       (13,579) (13,579)
Balances at Mar. 31, 2025 $ 1 $ 1,145,083   $ (979,101) $ 165,983
Balance (in shares) at Mar. 31, 2025 50,001       50,001